LYC Healthcare Berhad (KLSE:LYC)

LYC Healthcare Berhad Cash Flow Statement

Financials in millions MYR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-21.57	-22.94	-17.07	-20.78	-19.19	-9.23
Depreciation & Amortization	18.29	18.36	17.65	15.45	9.29	7.61
Other Amortization	0.81	0.81	-	-	-	-
Loss (Gain) From Sale of Assets	3.43	3.43	-1.86	0.05	-	-0.15
Asset Writedown & Restructuring Costs	0.93	0.93	3.52	0.89	1.1	0.01
Loss (Gain) From Sale of Investments	-	-	0.33	-0.8	-	-
Loss (Gain) on Equity Investments	0.03	0.03	0.19	1.4	2.23	0.51
Provision & Write-off of Bad Debts	0.18	0.18	0.3	1.28	0.23	0.19
Other Operating Activities	3.12	17.51	17.35	12.82	14.43	7.76
Change in Accounts Receivable	-1.86	-1.86	-6.92	-7.06	-3.09	-2.24
Change in Inventory	0.37	0.37	1.98	-0.91	-1.9	-0.34
Change in Accounts Payable	12.77	12.77	13.59	4.42	1.82	-3.13
Change in Unearned Revenue	-1.11	-1.11	-0.67	3.97	0.07	-0.65
Operating Cash Flow	20.73	28.47	28.39	10.74	4.99	0.34
Operating Cash Flow Growth	-51.42%	0.29%	164.46%	115.04%	1351.16%	-

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-3	-2	-5.65	-5.7	-2.53	-2.88
Sale of Property, Plant & Equipment	-0.59	1.17	0.06	0.47	0	0.02
Cash Acquisitions	-	-	-	-10.98	-30.66	-31.7
Divestitures	-	-	5.3	-	12.11	-
Investment in Securities	-	-	-	0.09	-1.13	-6.6
Other Investing Activities	-2.51	-2.18	0.81	-9.63	10.08	3.36
Investing Cash Flow	-6.11	-3	0.51	-25.75	-12.13	-37.8

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Issued	-	-	-	0.56	11.03	0.17
Total Debt Issued	-	-	-	0.56	11.03	0.17
Long-Term Debt Repaid	-	-13.8	-19.01	-18.81	-6.41	-4.94
Lease Payments	-5.67	-11.95	-11.52	-8.07	-5.71	-3.77
Total Debt Repaid	-4.59	-13.8	-19.01	-18.81	-6.41	-4.94
Net Debt Issued (Repaid)	-4.59	-13.8	-19.01	-18.25	4.62	-4.77
Issuance of Common Stock	0	1.41	-	10.89	33.37	17.79
Other Financing Activities	-10.84	-12.51	-15.68	-11.85	-12.03	30.4
Financing Cash Flow	-15.43	-24.89	-34.69	-19.21	25.95	43.42

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	1.32	-0.68	-0.69	-1.25	-0.44	-0.05
Net Cash Flow	3.38	-0.11	-6.47	-35.48	18.37	5.92

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	17.72	26.47	22.74	5.03	2.46	-2.54
Free Cash Flow Growth	-56.37%	16.40%	351.86%	104.68%	-	-
Free Cash Flow Margin	12.93%	19.60%	14.62%	3.90%	2.67%	-3.93%
Free Cash Flow Per Share	0.02	0.04	0.03	0.01	0.00	-0.01
Levered Free Cash Flow	23.68	20.04	9.78	-2.52	7.52	-12.68
Unlevered Free Cash Flow	29.49	26.44	16.47	3.4	14.53	-7.2
Free Cash Flow After Leases	12.06	14.52	11.23	-3.04	-3.25	-6.31

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	8.07	10.23	8.28	10.01	10.44	6
Cash Income Tax Paid	2.61	2.61	3.84	4.06	3.95	3.14
Change in Working Capital	15.51	10.16	7.98	0.42	-3.1	-6.36

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 18, 2026

Data Sources Report a data error